Skip to main content
News

China Isotope & Radiation Corporation (CIRC) and OncoBeta sign distribution agreement for Tungsten 188/Rhenium-188 generators

Beijing, China and Garching near Munich, Germany, Tuesday 30th June 2020. CIRC and OncoBeta today announced that they have signed an agreement for the…

Read more

How can you Reduce the Risk of Skin Cancer?

Skin Cancer is the most common type of cancer in the world 1. Ultraviolet (UV) Radiation exposure is one of the major causes of melanoma and…

Read more

COVID-19: We are here for you.

To our Valued Patients, Customers and Health Care providers, As we navigate through these trying times surrounding the Coronavirus (COVID-19)…

Read more

B.J. Madan & Co India and OncoBeta announce exclusive distribution agreement for W/Re-188 generators.

New Delhi, India and Garching near Munich, Germany, 6th March, 2020. B.J Madan & Co and OncoBeta announced the execution of an exclusive distribution…

Read more

RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada.

RadioMedix and OncoBeta today announced the execution of an exclusive distribution agreement for the next generation of W/Re-188 generators in the…

Read more

Oncobeta chosen as one of the Trailblazing Companies to Watch in 2019

OncoBeta- A Pioneer And Innovator In The Epidermal Radioisotope Therapy Sector Skin is the largest organ of the body and represents the first barrier…

Read more

OncoBeta® receives Corporate Excellence Award 2019

OncoBeta recognized as the Most Compassionate Skin Cancer Therapy Provider in 2019.

 

OncoBeta®, a Medical Device Company specialized in innovative…

Read more

First non-melanoma skin cancer patients treated with the Rhenium-SCT® in Germany

The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau

 

Dr. Lutz-Hendrik…

Read more

OncoBeta® chosen as a 2019 Red Herring Top 100 Europe Winner

OncoBeta® GmbH, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs),…

Read more

OncoBeta® GmbH is listed as one of the Top 20 MedTech Outlook Solution Providers in Europe

OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers…

Read more